BioNumerik Improvements Included. Following the Effective Date and during the term of this Agreement, without any further payment, BIONUMERIK shall promptly and fully disclose and grant (a) an exclusive royalty-free license to KI PHARMA to use any BioNumerik Improvements in the Territory for the purpose of development and commercialization of the Venture Products in the Territory in accordance of this Agreement, and (b) a non-exclusive royalty free license to GRELAN to use such Improvements in the Territory for the purpose of development of Venture Products in the Territory in accordance with this Agreement. In addition, BIONUMERIK hereby grants GRELAN effective as of the Effective Date (a) a non-exclusive, perpetual, fully paid-up royalty-free license, with the right to sublicense, to use all BioNumerik Improvements related only to Venture Products GR outside the Territory for the purpose of development and commercialization of such products outside the Territory, and (b) a nonexclusive, perpetual (but only after the expiration or termination of this Agreement), fully paid-up royaltyfree license, with the right to sublicense, to use such BioNumerik Improvements related only to Venture Products GR in the Territory for the purpose of development and commercialization of such products in the Territory.
Appears in 4 contracts
Samples: Joint Venture Agreement (BioNumerik Pharmaceuticals, Inc.), Joint Venture Agreement (Bionumerik Pharmaceuticals Inc), Joint Venture Agreement (Bionumerik Pharmaceuticals Inc)